carnitine has been researched along with Dementia in 16 studies
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The acute effects of intravenously administered L-acetylcarnitine (LAC) were evaluated with single-photon emission computed tomography (SPECT) and 99mTc-hexamethylpropyleneamine oxime in 30 demented patients (21 with a clinical diagnosis of Alzheimer's dementia and 9 with mixed-type dementia)." | 7.67 | Single-photon emission computed tomography studies with 99mTc-hexamethylpropyleneamine oxime in dementia: effects of acute administration of L-acetylcarnitine. ( Battistin, L; Borsato, N; Calvani, M; Da Col, C; Dam, M; Ferlin, G; Perlotto, N; Pizzolato, G; Saitta, B, 1989) |
| "Twenty-nine patients with probable Alzheimer's disease, 18 with mild cognitive impairment of the amnestic type, 24 with subjective memory complaint and 46 healthy subjects were enrolled in the study, and the levels of carnitine and acyl-carnitines were measured by tandem mass spectrometry." | 5.43 | Serum Levels of Acyl-Carnitines along the Continuum from Normal to Alzheimer's Dementia. ( Angiolillo, A; Corbi, G; Corso, G; Cristofano, A; Di Costanzo, A; Intrieri, M; La Marca, G; Russo, C; Sapere, N; Scapagnini, G; Vitale, M, 2016) |
| "We examined prospective associations of TMAO, γ-butyrobetaine, crotonobetaine, carnitine, choline, and betaine with risk of cognitive impairment and dementia among older adults aged 65 years and older in the Cardiovascular Health Study (CHS)." | 4.12 | Longitudinal Associations of Plasma TMAO and Related Metabolites with Cognitive Impairment and Dementia in Older Adults: The Cardiovascular Health Study. ( de Oliveira Otto, MC; Fretts, A; Hazen, SL; Lai, HTM; Lee, Y; Lemaitre, RN; Li, XS; Lopez, O; Mozaffarian, D; Nemet, I; Newman, AB; Siscovick, DS; Tang, WHW; Wang, M; Wang, Z, 2022) |
| "The acute effects of intravenously administered L-acetylcarnitine (LAC) were evaluated with single-photon emission computed tomography (SPECT) and 99mTc-hexamethylpropyleneamine oxime in 30 demented patients (21 with a clinical diagnosis of Alzheimer's dementia and 9 with mixed-type dementia)." | 3.67 | Single-photon emission computed tomography studies with 99mTc-hexamethylpropyleneamine oxime in dementia: effects of acute administration of L-acetylcarnitine. ( Battistin, L; Borsato, N; Calvani, M; Da Col, C; Dam, M; Ferlin, G; Perlotto, N; Pizzolato, G; Saitta, B, 1989) |
| "Twenty-nine patients with probable Alzheimer's disease, 18 with mild cognitive impairment of the amnestic type, 24 with subjective memory complaint and 46 healthy subjects were enrolled in the study, and the levels of carnitine and acyl-carnitines were measured by tandem mass spectrometry." | 1.43 | Serum Levels of Acyl-Carnitines along the Continuum from Normal to Alzheimer's Dementia. ( Angiolillo, A; Corbi, G; Corso, G; Cristofano, A; Di Costanzo, A; Intrieri, M; La Marca, G; Russo, C; Sapere, N; Scapagnini, G; Vitale, M, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (18.75) | 18.7374 |
| 1990's | 11 (68.75) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| de Oliveira Otto, MC | 1 |
| Li, XS | 1 |
| Wang, Z | 1 |
| Siscovick, DS | 1 |
| Newman, AB | 1 |
| Lai, HTM | 1 |
| Nemet, I | 1 |
| Lee, Y | 1 |
| Wang, M | 1 |
| Fretts, A | 1 |
| Lemaitre, RN | 1 |
| Tang, WHW | 1 |
| Lopez, O | 1 |
| Hazen, SL | 1 |
| Mozaffarian, D | 1 |
| Cristofano, A | 1 |
| Sapere, N | 1 |
| La Marca, G | 1 |
| Angiolillo, A | 1 |
| Vitale, M | 1 |
| Corbi, G | 1 |
| Scapagnini, G | 1 |
| Intrieri, M | 1 |
| Russo, C | 1 |
| Corso, G | 1 |
| Di Costanzo, A | 1 |
| Acierno, G | 1 |
| Recchia, G | 2 |
| Zerbini, O | 1 |
| Fabbri, L | 1 |
| Neri, M | 1 |
| Cortelloni, C | 1 |
| De Vreese, L | 1 |
| Roncolato, M | 1 |
| Meneghetti, M | 1 |
| Bamfi, F | 1 |
| Girelli, M | 1 |
| Cipolli, C | 1 |
| Chiari, G | 1 |
| Genazzani, E | 1 |
| Goety, CG | 1 |
| Tanner, CM | 1 |
| Cohen, JA | 1 |
| Thelen, JA | 1 |
| Carroll, VS | 1 |
| Klawans, HL | 1 |
| Fariello, RG | 1 |
| Passeri, M | 2 |
| Cucinotta, D | 2 |
| Bonati, PA | 2 |
| Iannuccelli, M | 3 |
| Parnetti, L | 1 |
| Senin, U | 1 |
| Garzya, G | 1 |
| Corallo, D | 1 |
| Fiore, A | 1 |
| Lecciso, G | 1 |
| Petrelli, G | 1 |
| Zotti, C | 1 |
| Sinforiani, E | 1 |
| Mauri, M | 1 |
| Costa, A | 1 |
| Merlo, P | 1 |
| Bono, G | 1 |
| Nappi, G | 1 |
| Battistin, L | 1 |
| Pizzolato, G | 1 |
| Dam, M | 1 |
| Da Col, C | 1 |
| Perlotto, N | 1 |
| Saitta, B | 1 |
| Borsato, N | 1 |
| Calvani, M | 1 |
| Ferlin, G | 1 |
| Ciotti, G | 1 |
| Nolfe, G | 1 |
11 trials available for carnitine and Dementia
| Article | Year |
|---|---|
[The use of 1-acetylcarnitine in (presenile and senile) Alzheimer's disease. Preliminary results].
Topics: Acetylcarnitine; Aged; Alzheimer Disease; Carnitine; Clinical Trials as Topic; Dementia; Double-Blin | 1983 |
[Aging of the population: the 2d demographic revolution].
Topics: Acetylcarnitine; Aged; Aged, 80 and over; Carnitine; Clinical Trials as Topic; Dementia; Demography; | 1990 |
[Clinical development of a drug for brain aging. Current limitations and future prospects].
Topics: Acetylcarnitine; Aged; Carnitine; Clinical Trials as Topic; Dementia; Diagnosis, Differential; Human | 1990 |
[Methodology of a clinical controlled study of L-acetylcarnitine].
Topics: Acetylcarnitine; Aged; Carnitine; Clinical Trials as Topic; Dementia; Humans; Middle Aged; Multicent | 1990 |
[Center monitoring and management of data bases].
Topics: Acetylcarnitine; Carnitine; Clinical Trials as Topic; Database Management Systems; Dementia; Humans; | 1990 |
[Effects of L-acetylcarnitine on mental deterioration in the aged: initial results].
Topics: Acetylcarnitine; Aged; Analysis of Variance; Behavior; Carnitine; Clinical Trials as Topic; Cognitio | 1990 |
[A controlled clinical study on the efficacy of L-acetylcarnitine in the treatment of mild-to-moderate mental deterioration in the aged. Conclusions].
Topics: Acetylcarnitine; Aged; Carnitine; Clinical Trials as Topic; Dementia; Humans; Middle Aged; Multicent | 1990 |
L-acetyl-carnitine in Huntington's disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia.
Topics: Acetylcarnitine; Adult; Aged; Carnitine; Dementia; Double-Blind Method; Female; Humans; Huntington D | 1990 |
Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
Topics: Acetylcarnitine; Aged; Carnitine; Cognition; Dementia; Double-Blind Method; Female; Humans; Male; Ra | 1990 |
Evaluation of the effects of L-acetylcarnitine on senile patients suffering from depression.
Topics: Acetylcarnitine; Aged; Aged, 80 and over; Carnitine; Clinical Trials as Topic; Dementia; Depressive | 1990 |
Mental impairment in aging: selection of patients, methods of evaluation and therapeutic possibilities of acetyl-L-carnitine.
Topics: Acetylcarnitine; Aged; Aged, 80 and over; Analysis of Variance; Carnitine; Dementia; Female; Humans; | 1988 |
5 other studies available for carnitine and Dementia
| Article | Year |
|---|---|
Longitudinal Associations of Plasma TMAO and Related Metabolites with Cognitive Impairment and Dementia in Older Adults: The Cardiovascular Health Study.
Topics: Animals; Betaine; Carnitine; Choline; Cognitive Dysfunction; Dementia; Medicare; Methylamines; Unite | 2022 |
Serum Levels of Acyl-Carnitines along the Continuum from Normal to Alzheimer's Dementia.
Topics: Aged; Alzheimer Disease; Analysis of Variance; Biomarkers; Body Mass Index; Calibration; Carnitine; | 2016 |
[Methodological premises of statistical analysis of the data].
Topics: Acetylcarnitine; Age Factors; Aged; Analysis of Variance; Carnitine; Data Interpretation, Statistica | 1990 |
Neuropsychological changes in demented patients treated with acetyl-L-carnitine.
Topics: Acetylcarnitine; Aged; Brain Ischemia; Carnitine; Dementia; Female; Humans; Male; Middle Aged; Pirac | 1990 |
Single-photon emission computed tomography studies with 99mTc-hexamethylpropyleneamine oxime in dementia: effects of acute administration of L-acetylcarnitine.
Topics: Acetylcarnitine; Aged; Alzheimer Disease; Carnitine; Dementia; Female; Humans; Injections, Intraveno | 1989 |